Biomedical Engineering Reference
In-Depth Information
[27] Tan ML, Choong PF, Dass CR. Recent developments in liposomes, microparticles and
nanoparticles for protein and peptide drug delivery. Peptides 2010;31:184-93.
[28] Sakuma S, Suzuki N, Kikuchi H, Hiwatari K, Arikawa K, Kishida A, et al. Oral peptide
delivery using nanoparticles composed of novel graft copolymers having hydrophobic
backbone and hydrophilic branches. Int J Pharm 1997;149:93-106.
[29] Kutchai HC. The gastrointestinal system. In: Berne RM, Levy MN, Koeppen BM, Stanton
BA, editors. Physiology. 4th ed. St. Louis, MO: Mosby-Year Book; 1998. p. 587-674.
[30] Fox SI. The Digestive system. In: Fox SI, editor. Human physiology. 9th ed. Columbus,
OH: McGraw  Hill; 2003:558-95.
[31] Egberts HJ, Koninkx JF, Dijk J, Mouwen JM. Biological and pathobiological aspects of
the glycocalyx of the small intestinal epithelium. a review. Vet Q 1984;6:186-99.
[32] Russell-Jones GJ, Aizpurua HJ. Vitamin B12: a novel carrier for orally presented anti-
gens. Proc Int Symp Control Release Bioact Mater 1988;15:142-3.
[33] Park, JY. Biophysical model approach to the mechanistic studies of intestinal absorption
of drugs. Ph.D. Thesis, The University of Michigan, Ann Arbor, Michigan; 1977.
[34] Sallee YL, Wilson FA, Dietschy JM. Determination of unidirectional uptake rates for lip-
ids across the intestinal brush border. J Lipid Res 1972;13:184-92.
[35] Rouge N, Buri P, Doelker E. Drug absorption sites in the gastrointestinal tract and dosage
forms for site specific delivery. Int J Pharm 1996;136:117-39.
[36] Madara JL. Functional morphology of epithelium of the small intestine Section 6. In:
Field M, Raymond AF, editors. Intestinal absorption and secretion—handbook of physi-
ology. Bethesda, MD: American Physiological Society; 1991. p. 83-120.
[37] Tomita M, Shiga M, Hayashi M, Awazu S. Enhancement of colonic drug absorption by
the paracellular permeation route. Pharm Res 1988;5:341-6.
[38] Pappenheimer JR. Physiological regulation of transepithelial impedance in the intestinal
mucosa of rats and hamsters. J Membr Biol 1987;100:137-48.
[39] Burton PS, Conradi RA, Hilgers AR. B) Mechanisms of peptide and protein absorption:
(2) Transcellular mechanism of peptide and protein absorption: passive aspects. Adv
Drug Deliv Rev 1991;7:365-86.
[40] Hebden JM, Wilson CG, Spiller RC, Gilchrist PJ, Blackshaw E, Frier ME, et al. Regional
differences in quinine absorption from the undisturbed human colon assessed using a
timed release delivery system. Pharm Res 1999;16:1087-92.
[41] Russell-Jones GJ. Carrier-mediated transport, oral drug delivery. In: Mathiowitz E,
editor. Encyclopedia of controlled drug delivery, vol. 1. New York, NY: John Wiley &
Sons; 1999. p. 173-84.
[42] Barthe L, Woodley J, Houin G. Gastrointestinal absorption of drugs: methods and stud-
ies. Fundamental Clin Pharmacol 1999;13:154-68.
[43] Russell-Jones GJ. The potential use of receptor-mediated endocytosis for oral drug deliv-
ery. Adv Drug Deliv Rev 1996;20:83-97.
[44] Swaan PW. Recent advances in intestinal macromolecular drug delivery via receptor-
mediated transport pathways. Pharm Res 1998;15:826-34.
[45] Ho NFH, Day JS, Barsuhn CL, Burton PS, Raub TJ. Biophysical model approaches to
mechanistic transepithelial studies of peptides. J Control Release 1990;11:3-24.
[46] Rathbone MJ, Hadgraft J. Absorption of drugs from the human oral cavity. Int J Pharm
1991;74:9-24.
[47] Charman WN, Porter CJH. Lipophilic prodrugs designed for intestinal lymphatic trans-
port. Adv Drug Deliv Rev 1996;19:149-69.
[48] Hamman JH, Enslin GM, Kotzé AF. Oral delivery of peptide drugs: barriers and develop-
ments. BioDrugs: Clin Immunotherap, Biopharm Gene Ther 2005;19:165-77.
Search WWH ::




Custom Search